Michael Dunn Reflects on all ASH25 Represents for the Bleeding Disorders Community
Michael Dunn, Vice President – Head of Rare Disease Portfolio at Genentech, shared on LinkedIn:
”I’m pausing to take a moment to reflect on all ASH25 represents for the bleeding disorders community – innovation, hope, progress.
I feel energized to be here.
Connecting with brilliant minds, learning about the latest advancements in hematology, and sharing how Genentech is advancing the standard of care for patients and their families.
I’m proud to be part of an organization that prioritizes standing alongside the hemophilia A community.
Every step forward is driven by our commitment to push the boundaries of what’s possible and deliver meaningful progress for people living with bleeding disorders.
A big thank you to the local Florida team for their above and beyond efforts at the booth Jeremy V., Lucila Ramirez Donaldson, William Lopez and to members of the leadership team who were representing our collective efforts for those with bleeding disorders Erik Lundgren, Tony Lin, Juliana Lagrasta Biondo, Gina Noh”
All from ASH25 featured in Hemostasis Today.
-
Dec 10, 2025, 17:22In the Fight for Hematology: Adetokunbo O’s Reflections from ASH25
-
Dec 10, 2025, 17:11Driving Innovation in Rare Blood Disorders: Jeff Schaffnit’s ASH 2025 Perspective
-
Dec 10, 2025, 16:37Arthur Allen – The New President-Elect of the Anticoagulation Forum Board of Directors
-
Dec 10, 2025, 16:29Matthew D Neal: An Oasis in the Platelet Desert?
-
Dec 10, 2025, 16:14Yashpal Singh Rawat: Fortis Memorial Research Institute Made Its Positive Mark at ASH
-
Dec 10, 2025, 14:57Elvira Grandone Announces the 1st ThrombUS+ Data Challenge
-
Dec 10, 2025, 14:18Love Preet Kalra on A Paradigm Shift in ICH
-
Dec 10, 2025, 13:37Aakanksha A: A Highlight of the Week Was Presenting Our ASH Poster
-
Dec 9, 2025, 23:37Thomas Reiser: Renew Your ISTH Membership for 2025